Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.
The Lancet(2018)
摘要
GlaxoSmithKline.
更多查看译文
关键词
kidney transplantation,randomised placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要